Target Price | $67.80 |
Price | $22.03 |
Potential |
207.76%
register free of charge
|
Number of Estimates | 10 |
10 Analysts have issued a price target Arcturus Therapeutics Ltd 2025 .
The average Arcturus Therapeutics Ltd target price is $67.80.
This is
207.76%
register free of charge
$140.00
535.50%
register free of charge
$25.00
13.48%
register free of charge
|
|
A rating was issued by 11 analysts: 11 Analysts recommend Arcturus Therapeutics Ltd to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Arcturus Therapeutics Ltd stock has an average upside potential 2025 of
207.76%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 157.75 | 179.26 |
23.42% | 13.64% | |
EBITDA Margin | -0.76% | -73.36% |
108.29% | 9,543.78% | |
Net Margin | -19.20% | -64.72% |
517.88% | 237.12% |
11 Analysts have issued a sales forecast Arcturus Therapeutics Ltd 2024 . The average Arcturus Therapeutics Ltd sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Arcturus Therapeutics Ltd EBITDA forecast 2024. The average Arcturus Therapeutics Ltd EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 Arcturus Therapeutics Ltd Analysts have issued a net profit forecast 2024. The average Arcturus Therapeutics Ltd net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.12 | -4.29 |
420.00% | 283.04% | |
P/E | negative | |
EV/Sales | 1.74 |
2 Analysts have issued a Arcturus Therapeutics Ltd forecast for earnings per share. The average Arcturus Therapeutics Ltd <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Arcturus Therapeutics Ltd stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Arcturus Therapeutics Ltd...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.